Diana Cao

902 total citations
32 papers, 649 citations indexed

About

Diana Cao is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Diana Cao has authored 32 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Diana Cao's work include HER2/EGFR in Cancer Research (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Diana Cao is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Diana Cao collaborates with scholars based in Australia, United States and Japan. Diana Cao's co-authors include Andrew M. Scott, Angela Rigopoulos, Graeme O’Keefe, Jaekyu Shin, Terrance G. Johns, Rachel S. Mulligan, Gary A. Cartwright, Kevin J. Barnham, Colin L. Masters and Catriona McLean and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Diana Cao

32 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Cao Australia 12 221 173 142 138 83 32 649
Angelica Quartino United States 17 390 1.8× 221 1.3× 176 1.2× 279 2.0× 99 1.2× 48 988
Tamar Berger United States 9 171 0.8× 257 1.5× 65 0.5× 75 0.5× 35 0.4× 13 665
Yiran Chen China 15 103 0.5× 217 1.3× 77 0.5× 132 1.0× 28 0.3× 48 658
Shinya Kagawa Japan 14 155 0.7× 113 0.7× 176 1.2× 42 0.3× 52 0.6× 59 722
Simon‐Peter Williams United Kingdom 17 115 0.5× 544 3.1× 307 2.2× 296 2.1× 37 0.4× 29 1.2k
Fausto Chionne Italy 14 334 1.5× 299 1.7× 34 0.2× 63 0.5× 80 1.0× 19 829
Vincent Vuaroqueaux France 16 73 0.3× 472 2.7× 54 0.4× 268 1.9× 60 0.7× 36 868
Severin Mairinger Austria 18 74 0.3× 215 1.2× 229 1.6× 658 4.8× 107 1.3× 66 980
Johann Stanek Austria 22 151 0.7× 284 1.6× 270 1.9× 1.0k 7.5× 292 3.5× 62 1.5k
Agnieszka Kulczyńska‐Przybik Poland 16 270 1.2× 299 1.7× 20 0.1× 131 0.9× 106 1.3× 65 755

Countries citing papers authored by Diana Cao

Since Specialization
Citations

This map shows the geographic impact of Diana Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Cao more than expected).

Fields of papers citing papers by Diana Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Cao. The network helps show where Diana Cao may publish in the future.

Co-authorship network of co-authors of Diana Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Cao. A scholar is included among the top collaborators of Diana Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Cao. Diana Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Diana, Joel R. Steele, Angela Rigopoulos, et al.. (2025). Altered Abundance of Barrier-Related Proteins in Brain Microvascular Endothelial Cells of the GL261 Mouse Model of Glioblastoma. Molecular Pharmaceutics. 22(11). 6658–6669. 1 indexed citations
2.
Parakh, Sagun, Nhi Huynh, Laura D. Osellame, et al.. (2025). Characterisation of mAb104 Antibody–Drug Conjugates Targeting a Tumour-Selective HER2 Epitope. Cancers. 17(18). 2995–2995. 1 indexed citations
3.
Wichmann, Christian, Ingrid J.G. Burvenich, Angela Rigopoulos, et al.. (2023). Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Nuclear Medicine and Biology. 122-123. 108366–108366. 5 indexed citations
4.
Cao, Diana, et al.. (2022). Effectiveness of telepharmacy diabetes services: A systematic review and meta-analysis. American Journal of Health-System Pharmacy. 79(11). 860–872. 14 indexed citations
5.
Burvenich, Ingrid J.G., Hui Gan, Angela Rigopoulos, et al.. (2021). Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3075–3088. 20 indexed citations
6.
Gan, Hui, Sagun Parakh, Andrew B. Lassman, et al.. (2021). Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin. Neuro-Oncology Advances. 3(1). vdab102–vdab102. 9 indexed citations
7.
Anderson, Mark G., Hugh D. Falls, Michael J. Mitten, et al.. (2020). Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody–Drug Conjugate. Molecular Cancer Therapeutics. 19(10). 2117–2125. 30 indexed citations
8.
Hernandez, Elvin A., et al.. (2020). Effectiveness of Telepharmacy Versus Face-to-Face Anticoagulation Services in the Ambulatory Care Setting: A Systematic Review and Meta-analysis. Annals of Pharmacotherapy. 55(9). 1084–1095. 6 indexed citations
9.
Cao, Diana, et al.. (2020). A Survey of Energy Drink Consumption and Associated Adverse Effects in Air Force Personnel. Military Medicine. 186(1-2). e143–e148. 7 indexed citations
10.
Cao, Diana, et al.. (2018). Considerations for Optimal Blood Pressure Goals in the Elderly Population: A Review of Emergent Evidence. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(3). 370–381. 5 indexed citations
11.
Chia, Puey Ling, Diana Cao, Angela Rigopoulos, et al.. (2018). Abstract 743: ABT-806-derived antibody-drug conjugates (ADCs) inhibit growth of malignant mesothelioma in vivo. Cancer Research. 78(13_Supplement). 743–743. 1 indexed citations
12.
13.
Burvenich, Ingrid J.G., Fook-Thean Lee, Graeme O’Keefe, et al.. (2016). Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers. EJNMMI Research. 6(1). 26–26. 15 indexed citations
14.
Cao, Diana, Lie‐Injo Luan Eng, Julie Dinh, et al.. (2015). Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients. Journal of Clinical Pharmacy and Therapeutics. 40(6). 635–639. 3 indexed citations
15.
16.
Rigopoulos, Angela, Diana Cao, Glenn A. Cartwright, et al.. (2014). Radiolabelling and evaluation of a novel sulfoxide as a PET imaging agent for tumor hypoxia. Nuclear Medicine and Biology. 41(5). 419–425. 5 indexed citations
17.
Burvenich, Ingrid J.G., Glenn A. Cartwright, Graeme O’Keefe, et al.. (2013). Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008. Clinical Cancer Research. 19(21). 5984–5993. 13 indexed citations
18.
Rigopoulos, Angela, Diana Cao, Glenn A. Cartwright, et al.. (2012). Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxia. Nuclear Medicine and Biology. 39(6). 871–882. 10 indexed citations
19.
Fodero‐Tavoletti, Michelle T., Nobuyuki Okamura, Shozo Furumoto, et al.. (2011). 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 134(4). 1089–1100. 266 indexed citations
20.
Gan, Hui, et al.. (2009). Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF‐κB and initiates tumour vascular normalization. Journal of Cellular and Molecular Medicine. 13(9b). 3993–4001. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelica Quartino Breakdown of academic impact, for papers by Tamar Berger Breakdown of academic impact, for papers by Yiran Chen Breakdown of academic impact, for papers by Shinya Kagawa Breakdown of academic impact, for papers by Simon‐Peter Williams Breakdown of academic impact, for papers by Fausto Chionne Breakdown of academic impact, for papers by Vincent Vuaroqueaux Breakdown of academic impact, for papers by Severin Mairinger Breakdown of academic impact, for papers by Johann Stanek Breakdown of academic impact, for papers by Agnieszka Kulczyńska‐Przybik
Rankless by CCL
2026